Computational design of CYP102A1 variants for the biosynthesis of a next-generation antiplatelet drug DT-678
Sun, Y.; Huang, X.; Zhang, J.; Osawa, Y.; Chen, Y. E.; Zhang, H.
Show abstract
Clopidogrel is a widely used antiplatelet prodrug to treat acute coronary syndromes. However, its clinical efficacy is hampered by ineffective bioactivation to produce the pharmacologically active metabolite (AM), leading to variability in antiplatelet response among different ethnic groups. To overcome the shortcomings of clopidogrel, DT-678 was developed by conjugating the AM to 3-nitropyridine-2-thiol via a mixed disulfide bond. It has been challenging to produce the conjugate in high yield by chemical synthesis. Here, we report the first de novo biosynthesis of DT-678 using engineered CYP102A1 variants. We applied structure-based computational design using UniDesign to generate three variants (UD4, UD5, and UD6) that enhanced the catalytic activity and selectivity toward DT-678 synthesis. Among them, UD6 demonstrated the highest total turnover number and DT-678-specific productivity under optimized conditions. Mechanistic analysis revealed that rapid enzyme inactivation, driven by reactive oxygen species (ROS) such as superoxide and hydrogen peroxide, limited overall yield. Remarkably, we found that ascorbic acid significantly protected CYP102A1 variants from inactivation and hence increased production yield. This work establishes a scalable enzymatic strategy for DT-678 biosynthesis and highlights the importance of combining protein engineering with redox control to overcome limitations in CYP-catalyzed reactions.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Structural Basis for Catalysis and Substrate Specificity of a LarA Racemase with a Broad Substrate Spectrum 94%
- Designed high-redox potential laccases exhibit high functional diversity 94%
- Enabling regiospecific di-halogenation in one-pot reactions using an engineered single-component flavin-dependent tryptophan halogenase 93%
Similar papers in this journal
- Structure and Mechanism of Avermitilol Synthase, a Sesquiterpene Cyclase that Generates a Highly Strained 6-6-3 Tricyclic Alcohol 94%
- Kinetic Characterization and Computational Modeling of the Escherichia coli Heptosyltransferase II: Exploring the Role of Protein Dynamics in Catalysis for a GT-B Glycosyltransferase 94%
- Mechanism Underlying Anti-Markovnikov Addition in the Reaction of Pentalenene Synthase 93%
Similar papers in this journal
- Structure-aided development of small molecule inhibitors of ENPP1, the extracellular phosphodiesterase of the immunotransmitter cGAMP 93%
- An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor. 92%
- Investigating the NRAS 5' UTR as a Target for Small Molecules 92%
Similar papers in this journal
- Novel exported bifunctional fusion enzymes with chorismate mutase and cyclohexadienyl dehydratase activity: shikimate pathway enzymes teamed up in no man's land 93%
- Development of a novel high-throughput screen for the identification of new inhibitors of protein S-acylation 93%
- Warfarin analogs target disulfide bond-forming enzymes and suggest a residue important for quinone and coumarin binding 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.